AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,734,000 | -41.2% | 49,530 | -10.2% | 0.01% | -43.5% |
| Q2 2020 | $2,949,000 | +70.2% | 55,140 | +12.9% | 0.02% | +35.3% |
| Q1 2020 | $1,733,000 | -37.9% | 48,832 | -16.4% | 0.02% | -19.0% |
| Q4 2019 | $2,789,000 | +63.0% | 58,412 | +10.6% | 0.02% | +50.0% |
| Q3 2019 | $1,711,000 | -27.7% | 52,802 | +11.2% | 0.01% | -26.3% |
| Q2 2019 | $2,368,000 | -26.4% | 47,480 | -0.5% | 0.02% | -26.9% |
| Q1 2019 | $3,219,000 | +43.4% | 47,730 | -2.0% | 0.03% | +36.8% |
| Q4 2018 | $2,245,000 | -43.6% | 48,698 | -5.6% | 0.02% | -26.9% |
| Q3 2018 | $3,978,000 | +2.4% | 51,579 | +11.9% | 0.03% | 0.0% |
| Q2 2018 | $3,884,000 | -3.1% | 46,109 | -5.9% | 0.03% | +160.0% |
| Q1 2018 | $4,009,000 | +37.3% | 49,024 | -4.0% | 0.01% | +42.9% |
| Q4 2017 | $2,920,000 | -29.1% | 51,064 | -17.2% | 0.01% | -30.0% |
| Q3 2017 | $4,117,000 | +28.1% | 61,676 | -1.3% | 0.01% | +11.1% |
| Q2 2017 | $3,214,000 | -0.3% | 62,462 | +13.2% | 0.01% | 0.0% |
| Q1 2017 | $3,223,000 | +53.6% | 55,192 | +9.8% | 0.01% | +50.0% |
| Q4 2016 | $2,098,000 | -50.1% | 50,272 | -36.9% | 0.01% | -53.8% |
| Q3 2016 | $4,208,000 | +54.4% | 79,656 | +22.5% | 0.01% | +44.4% |
| Q2 2016 | $2,725,000 | -2.9% | 65,039 | -5.9% | 0.01% | 0.0% |
| Q1 2016 | $2,806,000 | -52.7% | 69,114 | -24.3% | 0.01% | -47.1% |
| Q4 2015 | $5,927,000 | -19.7% | 91,300 | -12.6% | 0.02% | -26.1% |
| Q3 2015 | $7,377,000 | -38.5% | 104,505 | -3.2% | 0.02% | -23.3% |
| Q2 2015 | $12,000,000 | +37.5% | 107,968 | +16.6% | 0.03% | +42.9% |
| Q1 2015 | $8,729,000 | +8.7% | 92,569 | +29.2% | 0.02% | +5.0% |
| Q4 2014 | $8,027,000 | +76.8% | 71,647 | -3.2% | 0.02% | +81.8% |
| Q3 2014 | $4,540,000 | +35.2% | 74,002 | +1.0% | 0.01% | +37.5% |
| Q2 2014 | $3,357,000 | – | 73,275 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |